Using CGM to predict prediabetes in cystic fibrosis
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Lungs & breathing clinical trials.
This study uses a continuous glucose monitor (CGM), a small sensor worn on the skin, to track blood sugar levels in people with cystic fibrosis (CF) who do not have diabetes or have prediabetes. The goal is to find patterns that might predict who will develop diabetes, so it can be caught earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cystic fibrosis (CF) and are between 12 and 55 years old.
- You do not have diabetes or have prediabetes (based on glucose tests).
- You are willing to wear a continuous glucose monitor and have a compatible smartphone.
- You are not pregnant, have not had an organ transplant, and do not take steroids or immunosuppressants.
- You do not have a serious medical condition that could affect glucose or interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
This study tests whether a continuous glucose monitor (CGM) can help people with prediabetes track their blood sugar levels over 20 days. You may be eligible if you have prediabetes, a BMI of 25 or higher, and a compatible smartphone.
This trial tests if wearing a continuous glucose monitor can help people with prediabetes understand their blood sugar patterns. You would wear a small sensor on your arm, and the results may help you make changes to prevent diabetes.
This study looks at how long-term diabetes affects people with cystic fibrosis. It helps researchers understand complications and improve care.
This study tests whether using a continuous glucose monitor (CGM)—a small device that tracks blood sugar throughout the day—can help people with prediabetes manage their condition better. You'll use the CGM with a smartphone app to see how your body responds to food and activity.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.